Form 4: RxSight CEO Receives Stock Grant
Insider Transaction (Form 4)
Aziz Mottiwala, President and CEO and a Director of RxSight, Inc., reported multiple transactions in common stock on July 24, 2026.
Summary
- Grant/award: acquired 2,312,138 Restricted Stock Unit on July 24, 2026; holds 2,312,138 after (Direct).
- Grant/award: acquired 571,286 Stock Option (right to buy) on July 24, 2026; holds 571,286 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Aziz Mottiwala — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-24 | Grant/award | Restricted Stock Unit | 2,312,138 | — | — | 2,312,138 |
| 2026-07-24 | Grant/award | Stock Option (right to buy) | 571,286 | — | — | 571,286 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-24 | Grant/award (2,312,138 shares) |
| 2026-07-24 | Grant/award (571,286 shares) |
Keywords
insider transaction, Form 4, RXST, RxSight, Inc., neutral, Aziz Mottiwala
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.